How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A new analysis shows that Actonel (risedronate sodium tablets) treatment up to 3 years significantly reduces the risk of vertebral and nonvertebral fragility fracture by 75% in postmenopausal women with osteopenia.
These data were presented during an oral presentation at The North American Menopause Society (NAMS) annual meeting.
"Postmenopausal women with a bone mineral density (BMD) score above the osteoporosis threshold could still be at risk of fracture since other factors besides low BMD contribute to fracture risk," said James A....
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
